Peripartum cardiomyopathy (PPCM) is a rare disease of unclear etiology with a frequent poor outcome, despite optimal medical therapy. Recent experimental data implicate a causal role of prolactin. We report a patient with PPCM who responded well to treatment with Bromocriptine in addition to standard therapy of heart failure.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ajog.2008.06.051 | DOI Listing |
Publication Analysis
Top Keywords
peripartum cardiomyopathy--a
4
cardiomyopathy--a treatment
4
treatment option
4
option inhibition
4
inhibition prolactin
4
prolactin secretion
4
secretion peripartum
4
peripartum cardiomyopathy
4
cardiomyopathy ppcm
4
ppcm rare
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!